About Forte Research
Forte Research is a Healthcare company based in Madison (United States) founded in 2000, and was acquired by Advarra in September 2019. Specialized software for clinical research compliance and efficiency is developed. The company has 181 employees. Its Indian entity Advarra India Private Limited reported revenue of βΉ62.58 Cr. Forte Research offers products and services including OnCore, Clinical Conductor, and eReg. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.
Company details
Forte Research Systems,has been developing specialized software for clinical research since 2000. The product family includes OnCore Enterprise Research, Allegro CTMS, and Overture EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble community, the Allegro Community, and Research Resonance Network, a technology-enabled community of sites pursuing data-driven excellence in clinical research operations.
- Headquarters Madison, United States
- Employees 181
- Stage Acquired
- SectorsHealthcare
- Website forteresearch.com
- Social LinkedIn X
- Acquired by Advarra (Sep 2019)
- Legal Name Advarra India Private Limited
- Date of Incorporation 03 Nov, 2010
Associated legal entities of Forte Research
Forte Research operates through Advarra India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Advarra India Private Limited CIN U72200KA2010PTC055745 | Active | 03 Nov 2010 | Bengaluru, Karnataka | ₹62.6 Cr | 249 | 5 | View details |
Products & Services of Forte Research
Forte Research offers a comprehensive portfolio of products and services, including OnCore, Clinical Conductor, and eReg.
System for operations and financial management in high-volume research sites.
Suite for optimizing clinical research workflows and site growth.
Platform for compliant and paperless regulatory processes.
Funding Insights of Forte Research
- Total Rounds 2
- First Round $550,000
(Sep 2014)
- Investors Count 1
All 2 funding rounds of Forte Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | Private Equity Round | β | Primus Capital | β | |
| Sep 2014 | $550,000 | Debt – Conventional | β | β | β |
2 investors in total: 2 institutional.
Investors in Forte Research
Forte Research has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Advarra and Primus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward the US and Canada. | primuscapital.com | Cleveland, United States | ||
Global research compliance services including IRB and consulting are provided. | 2017 | advarra.com | Columbia, United States |
Investor details for Forte Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Advarra India Private Limited (Forte Research)
Advarra India Private Limited is the primary company behind Forte Research. The board of Advarra India Private Limited currently have 5 directors; the longest-serving is Orla Elizabeth Mester, appointed in 2017. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Orla Elizabeth Mester DIN 08016955 | Director | 13 Dec 2017 | 8 yrs 11 mo | Advarra India Private Limited |
| Vinaykumar Venkatachalapathi Nama DIN 08087724 | Whole-time director | 11 May 2018 | 8 yrs 6 mo | Advarra India Private Limited |
| Scott Edward Uebele DIN 10597595 | Director | 08 May 2024 | 2 yrs 6 mo | Advarra India Private Limited |
| Swetha Raju DIN 10692573 | Whole-time director | 13 Sep 2024 | 2 yrs 2 mo | Advarra India Private Limited |
| Marco Vincent Capasso DIN 08621820 | Director | 19 May 2025 | 1 yr 5 mo | Advarra India Private Limited |
Financials of Forte Research
Figures of Advarra India Private Limited, the primary company behind Forte Research, for FY 2025. Revenue was ₹62.58 Cr (+55% year on year). Net profit was ₹5.86 Cr (9% margin). EBITDA was ₹11.53 Cr (18% margin). Revenue has grown at a compounded annual rate of +50% over three years and +37% over five years.
- ₹62.58 CrRevenue · FY 2025 · +55% YoY
- ₹5.86 CrNet profit · 9% margin
- ₹11.53 CrEBITDA · 18% margin
- ₹1 LakhPaid-up capital
- 249Employees (provident fund records)
- +50%Revenue CAGR, 3 years
- +37%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Advarra India Private Limited are on its company page.
Detailed financial statements for Forte Research
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Forte Research
4 dated milestones of Forte Research across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Forte Research is founded.
- Funding First funding round of $550K.
- Funding Latest funding round, Private Equity Round,.
- Exit Acquired by Advarra.
Competitors of Forte Research
Forte Research has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. |
Detailed competitors of Forte Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Forte Research
Websites that share an audience with Forte Research (forteresearch.com).
Websites whose visitors overlap most with Forte Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pacra.org | pacra.org | 100% | #12,073,368 | β | |
| clintec.com | 100% | View details | |||
| clinicalrm.com | 99% | View details | |||
chcuk.co.uk | chcuk.co.uk | 98% | β | ||
| xstrahl.com | 62% | 4.8K | #4,200,261 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 9 similar websites and full traffic analytics for Forte Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Forte Research (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Forte Research
Complete news archive for Forte Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Forte Research
Forte Research was founded in 2000 and raised its 1st funding round 14 years after it was founded.
Forte Research is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Forte Research has 181 employees.
The primary company behind Forte Research, Advarra India Private Limited, reported revenue of βΉ62.58 Cr for FY 2025, up 55% year on year.
Forte Research Systems,has been developing specialized software for clinical research since 2000. The product family includes OnCore Enterprise Research, Allegro CTMS, and Overture EDC. Forte provides complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. With a strong belief in community and standards-based development, Forte also facilitates the Onsemble community, the Allegro Community, and Research Resonance Network, a technology-enabled community of sites pursuing data-driven excellence in clinical research operations.
Forte Research offers OnCore, Clinical Conductor, and eReg.
Forte Research has 2 investors. Key investors include Advarra, and Primus Capital.
Forte Research operates through Advarra India Private Limited.
Yes. Forte Research was acquired by Advarra in September 2019.
The legal entities of Forte Research currently have 5 directors, including Marco Vincent Capasso, Scott Edward Uebele, Orla Elizabeth Mester and others.

